Acronyme: KidsCancerKinome


Titre complet: Selecting and validating drug targets from the human kinome for high risk paediatric cancers


Site internet

Date de début: 1er Novembre 2006

Durée du projet: 36 mois

Budget: 3,8 millions €

Programme: 6e PCRD

Ligne d’action: LSH-2005-2.2.0-3: Innovative diagnostic approaches and novel therapies of childhood cancers – STREP


Consortium:

- Coordinateur: INSTITUT GUSTAVE ROUSSY (Contact: Gilles Vassal)

- Academisch Medisch Centrum

- UNIVERSITY OF NEWCASTLE UPON TYNE

- Erasmus MC - Sophia Children's Hospital

- THE INSTITUTE OF CANCER RESEARCH

- Institut Curie

- University Hospital Muenster

- Universitätsklinikum Bonn

- Istituti Ortopedici Rizzoli

- France Europe Innovation

- Santaris Pharma A/S